0 Bewertungen0% fanden dieses Dokument nützlich (0 Abstimmungen)
21 Ansichten1 Seite
A reviewer is at the wellcome trust Sanger institute, hinxton, cb10 1SA, the UK. He says anti-microbial drugs are becoming increasingly ineffective against infections. The reviewer says the u.s. Needs to rethink its approach to biomedical research.
A reviewer is at the wellcome trust Sanger institute, hinxton, cb10 1SA, the UK. He says anti-microbial drugs are becoming increasingly ineffective against infections. The reviewer says the u.s. Needs to rethink its approach to biomedical research.
A reviewer is at the wellcome trust Sanger institute, hinxton, cb10 1SA, the UK. He says anti-microbial drugs are becoming increasingly ineffective against infections. The reviewer says the u.s. Needs to rethink its approach to biomedical research.
highways to relieve trafc congestion eases things for a while but induces additional driv- ing until the roads are again clogged. Fund- ing agencies and research organizations should make the changes that would gradu- ally adjust the current excess supply of new scientists to match demand and prevent new funding from simply inducing expansion that recreates excess supply. Only then could we have a productive discussion about the ben- ets of additional public funding. References and Notes 1. S. Rosen, K. Murphy, J. Scheinkman, J. Polit. Econ. 102, 468 (1994). 2. Teitelbaum identies ve cycles. Denoted by what trig- gered the initial boom, these are: the start of the Cold War in the 1950s, Sputnik, the War on Cancer and Rea- gan defense budget, the 1990s high-tech boom and Y2K panic, and the Clinton-Bush doubling of the NIH budget. 3. www.nap.edu/openbook.php?record_id=11463. 4. www.nap.edu/openbook.php?record_id=12999. 5. http://dx.doi.org/10.1787/888932486659. 6. M. S. Teitelbaum, Science 321, 644645 (2008). 7. P. Stephan, How Economics Shapes Science (Harvard Univ. Press, Cambridge, MA, 2012); reviewed in ( 10). 8. NIH, Biomedical research work-force working group report (NIH, Bethesda, MD, 2012); http://acd.od.nih. gov/biomedical_research_wgreport.pdf. 9. P. Stephan, The Endless Frontier: Reaping what Bush sowed?, National Bureau of Economic Research Work- ing Paper No. 19687 (2013). 10. M. Feldman, Science 335, 1171 (2012). 10.1126/science.1252696 The reviewer is at the Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, UK. E-mail: am24@sanger.ac.uk M ost people recognize that anti- microbial drugs are becoming increasingly ineffective, due to the rise of antimicrobial resistance (AMR). The incredible adaptability of microbes and the strong and varied selection pressures to which they are exposed compromise our abil- ity to fight infections, and many common procedures (from hip replacements to cancer therapies) carry greater risks. This has been highlighted in recent government reports such as the UK Five Year Antimicrobial Resis- tance Strategy 2013 to 2018 ( 1) and the U.S. Centers for Disease Control and Preventions Antibiotic Resistance Threats in the United States, 2013 ( 2). With very few new drugs in the pipeline, there is no doubt that the increas- Antibiotics and Collateral Damage PUBLIC HEALTH Alison E. Mather ing resistance to antimicrobials poses a seri- ous threat to human and animal health. While AMR can be observed and mea- sured on relatively short time scales, there are other consequences to the use of antimi- crobials and the less frequently considered sanitizers and disinfectants. Their long-term effects, at both individual and population levels, have rarely been addressed and are the central themes in Martin Bla- sers Missing Microbes. Blaser (an infectious disease special- ist at New York University) has dedicated decades to investi- gating how our use of antimi- crobials over the past 70 years or so relates to the phenomena of obesity, food allergies, asthma, and heart- burn, epidemics he refers to as our mod- ern plagues. He argues that changes to our microbiotathe collection of microbes in our bodies, which helps us digest our food, clot our blood, and protect us from invading pathogensare responsible for many human ills of the 21st century. Blaser sets the scene by portraying the complexity and diversity of microbial popu- lations and their interactions within human bodies. He has a particular and personal interest in Helicobacter pylori, a bacterium that for years has been associated with gastri- tis and ulcers. Whereas the organism is often portrayed as a villain, Blaser instead pro- motes its dual nature, arguing that its absence is associated with different disorders, an example being gastroesophageal reux dis- ease. Illustrating his points with a combina- tion of data and personal anecdote, he walks readers through the processes by which the use of antimicrobials changes the nature and composition of the resident microbial popu- lations that have evolved with us and notes how certain bacteria, such as H. pylori, are disappearing. In doing so, Blaser argues that we are interfering with our immune systems and other key biological processes and thus predisposing ourselves to these modern epi- demics. In another example, he draws an analogy between the frequent prescription of antimicrobials in children (often for viral infections on which they have no impact) and the provision of antimicrobials for growth promotion in food animals, inadvertently fattening [our children] up. As the author, to his credit, recognizes, the strength of evidence for the association between changing microbiota and these dis- eases is, without doubt, variable. The dis- eases are complex and multifactorial, and, interesting though Blasers observations are, for most of these illnesses a full understand- ing of causal relationships lies some way off. Importantly, he makes clear the critical dis- tinction between association and causation, and his explanations of ecological and epi- demiological concepts are among the books strong points. So too are his descriptions of necessary but not sufficient factors and the importance of seeking other vantage points from which to view ones data. There can be little dis- agreement with Blasers con- cern that we are now facing the doomsday scenario of an antibiotic winter. In dis- cussing that, he shifts from the long-term, unintended conse- quences of antimicrobial use and focuses instead on the more immediate prospects of untreatable resistant infections and human populations, with their disrupted microbiota, becoming more susceptible to pathogens. Expressed in a style ranging from moder- ate to strongly assertive, many of Blasers views are contentious. However, new ideas and fresh approaches are best generated from intellectual sandpits and the tails of the dis- tribution of opinions. Readable and challeng- ing, Missing Microbes provides a stimulus with which to probe existing dogma. References 1. www.gov.uk/government/uploads/system/uploads/attach- ment_data/le/244058/20130902_UK_5_year_AMR_ strategy.pdf. 2. www.cdc.gov/drugresistance/threat-report-2013/. C R E D I T :
D A V I D
S H O E M A K E R / C O U R T E S Y
H E N R Y
H O L T
A N D
C O M P A N Y 10.1126/science.1252914 Missing Microbes How the Overuse of Antibiotics Is Fueling Our Modern Plagues by Martin J. Blaser Holt, New York, 2014. 288 pp. $28. ISBN 9780805098105. Published by AAAS
o n
M a y
5 ,
2 0 1 4 w w w . s c i e n c e m a g . o r g D o w n l o a d e d
Oral and Maxillofacial Surgery Clinics, Volume 15, Issue 1, Pages 1-166 (February 2003), Current Concepts in The Management of Maxillofacial Infections
Antibacterial activities of the methanol extracts of Albizia adianthifolia, Alchornea laxiflora, Laportea ovalifolia and three other Cameroonian plants against multi-drug resistant Gram-negative bacteria